Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn’s disease – A controlled clinical trial-Reference-Cited by-同舟云学术

Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn’s disease – A controlled clinical trial

Published:2010-04 Issue:5 Volume:17 Page:305-309
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Krebs Simone,Omer Talib N.,Omer Bilal

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference34 articles.

1. Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve steroid dependent chronic active Crohn’s disease in a pilot study;Bauditz;Gut,1997

2. Cytomegalovirus infection of the colon: a possible tool in exacerbation of inflammatory bowel disease;Berk;Am. J. Gastroenterol.,1985

3. Development of a Crohn’s disease activity index. National cooperative Crohn’s disease study;Best;Gastroenterology,1976

4. Secondary metabolites of Artemisia annua and their biological activity;Bhakuni;Antiviral Res.,2001

5. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation;Braegger;Lancet,1992

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of inflammatory bowel disease from the perspective of Persian medicine;EXPLORE;2024-11

2. LC–MS/MS-QTOF analysis of Anodendron parviflorum (Roxb.) leaves extract and exploring its antioxidant, antimicrobial, and cytotoxic potential;Future Journal of Pharmaceutical Sciences;2024-09-10

3. Comparative study of different hexane extracts from Algerian Artemisia absinthium and Artemisia herba-alba : GC-MS profile, artemisinin content, and antioxidant properties;Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology;2024-08-08

4. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

5. Emerging Natural Therapies for the Treatment of Inflammatory Bowel Disease;Current Pharmaceutical Biotechnology;2024-04-22